Tuesday, February 4, 2014

Rockwell Medical Completes Long-Term Safety Study for Iron Maintenance Drug Triferic(TM)

Rockwell Medical, Inc. , a fully-integrated biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with innovative products and services for the treatment of iron replacement, ...



from Content Keyword RSS http://ift.tt/1ij6ZMj

via IFTTT

No comments:

Post a Comment

Total Pageviews